SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress

Genes and Cancer

Volumn 4, Issue 3-4, 2013, Pages 125-134

  McBurney, Michael W ^a,b   Clark Knowles, Katherine V ^a,b   Caron, Annabelle Z ^a,b   Gray, Douglas A ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

nutritional stress; oncogenesis; protein deacetylation; scale free network

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN P53; RESVERATROL; RETINOBLASTOMA PROTEIN; SIRTUIN 1;

ADAPTIVE BEHAVIOR; ARTICLE; AUTOPHAGY; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CHRONIC STRESS; DNA MODIFICATION; ENZYME ACTIVITY; ENZYME REGULATION; EVOLUTIONARY ADAPTATION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOTE; HUMAN; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; NEOPLASM; NONHUMAN; PHENOTYPE; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIRT1 GENE;

EID: 84882772777     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912474893     Document Type: Article

References (215)

1. Anderson RM,Weindruch R.The caloric restriction paradigm: implications for healthy human aging.Am J Hum Biol. 2012;24 (2): 101-6.
2. Massudi H,Grant R,Braidy N,Guest J,Farnsworth B,Guillemin GJ.Age-associated changes in oxidative stress and NAD(+) metabolism in human tissue.PLoS ONE. 2012;7 (7): e42357.
3. Morris BJ.Seven sirtuins for seven deadly diseases of aging.Free Radic Biol Med. 2012;:.
4. Imai S,Armstrong CM,Kaeberlein M,Guarente L.Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.Nature. 2000;403 (6771): 795-800.
5. Smith JS,Brachmann CB,Celic I,et al.A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.Proc Natl Acad Sci U S A. 2000;97 (12): 6658-63.
6. Landry J,Sutton A,Tafrov ST,et al.The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.Proc Natl Acad Sci U S A. 2000;97 (11): 5807-11.
7. Brachmann CB,Sherman JM,Devine SE,Cameron EE,Pillus L,Boeke JD.The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability.Genes Dev. 1995;9 (23): 2888-902.
8. Frye RA.Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.Biochem Biophys Res Commun. 1999;260 (1): 273-9.
9. Frye RA.Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins.Biochem Biophys Res Commun. 2000;273 (2): 793-8.
10. Suka N,Luo K,Grunstein M.Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin.Nat Genet. 2002;32 (3): 378-83.
11. Kimura A,Umehara T,Horikoshi M.Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing.Nat Genet. 2002;32 (3): 370-7.
12. Guarente L.Sir2 links chromatin silencing, metabolism, and aging.Genes Dev. 2000;14 (9): 1021-6.
13. Kaeberlein M,McVey M,Guarente L.The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.Genes Dev. 1999;13 (19): 2570-80.
14. Salvi JS,Chan JN,Pettigrew C,Liu TT,Wu JD,Mekhail K.Enforcement of a lifespan-sustaining distribution of Sir2 between telomeres, mating-type loci, and rDNA repeats by Rif1.Aging Cell. 2012;:.
15. Orlandi I,Bettiga M,Alberghina L,Nystrom T,Vai M.Sir2-dependent asymmetric segregation of damaged proteins in ubp10 null mutants is independent of genomic silencing.Biochim Biophys Acta. 2010;1803 (5): 630-8.
16. Tissenbaum HA,Guarente L.Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans.Nature. 2001;410 (6825): 227-30.
17. Garsin DA,Villanueva JM,Begun J,et al.Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens.Science. 2003 1921;300 (5627):.
18. Burnett C,Valentini S,Cabreiro F,et al.Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila.Nature. 2011;477 (7365): 482-5.
19. Lemieux ME,Yang X,Jardine K,et al.The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals.Mech Ageing Dev. 2005;126 (10): 1097-105.
20. Kang H,Suh JY,Jung YS,Jung JW,Kim MK,Chung JH.Peptide switch is essential for sirt1 deacetylase activity.Mol Cell. 2011;44 (2): 203-13.
21. Blander G,Olejnik J,Krzymanska-Olejnik E,et al.SIRT1 shows no substrate specificity in vitro.J Biol Chem. 2005;280 (11): 9780-5.
22. Chen Y,Zhao W,Yang JS,et al.Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways.Mol Cell Proteomics. 2012;11 (10): 1048-62.
23. Bouras T,Fu M,Sauve AA,et al.SIRT1 deacetylation and repression of P300 involves lysine residues 1020/1024 within the cell-cycle regulatory domain 1.J Biol Chem. 2005;280 (11): 10264-76.
24. Wang J,Chen J.SIRT1 regulates autoacetylation and HAT activity of Tip60.J Biol Chem. 2010;285 (15): 11458-64.
25. Peng L,Ling H,Yuan Z,et al.SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60.Mol Cell Biol. 2012;32 (14): 2823-36.
26. Luo J,Nikolaev AY,Imai S,et al.Negative control of p53 by Sir2alpha promotes cell survival under stress.Cell. 2001;107 (2): 137-48.
27. Vaziri H,Dessain SK,Eaton EN,et al.hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.Cell. 2001;107 (2): 149-59.
28. Jin Q,Yan T,Ge X,Sun C,Shi X,Zhai Q.Cytoplasm-localized SIRT1 enhances apoptosis.J Cell Physiol. 2007;213 (1): 88-97.
29. Lara E,Mai A,Calvanese V,et al.Salermide, a sirtuin inhibitor with a strong cancer-specific proapoptotic effect.Oncogene. 2009;28 (6): 781-91.
30. Lee IH,Cao L,Mostoslavsky R,et al.A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy.PNAS. 2008;105 (9): 3374-9.
31. Zhang Y,Zhang M,Dong H,et al.Deacetylation of cortactin by SIRT1 promotes cell migration.Oncogene. 2009;28 (3): 445-60.
32. Chu F,Chou PM,Zheng X,Mirkin BL,Rebbaa A.Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.Cancer Res. 2005;65 (22): 10183-7.
33. Wang RH,Sengupta K,Li C,et al.Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.Cancer Cell. 2008;14 (4): 312-23.
34. Raval AP,Dave KR,Perez-Pinzon MA.Resveratrol mimics ischemic preconditioning in the brain.J Cereb Blood Flow Metab. 2006;26 (9): 1141-7.
35. Pruitt K,Zinn RL,Ohm JE,et al.Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.PLoS Genet. 2006;2 (3): e40.
36. O'Hagan HM,Mohammad HP,Baylin SB.Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.PLoS Genet. 2008;4 (8): e1000155.
37. Asher G,Gatfield D,Stratmann M,et al.SIRT1 regulates circadian clock gene expression through PER2 deacetylation.Cell. 2008;134 (2): 317-28.
38. Nakahata Y,Kaluzova M,Grimaldi B,et al.The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control.Cell. 2008;134 (2): 329-40.
39. Fulco M,Schiltz RL,Iezzi S,et al.Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state.Mol Cell. 2003;12 (1): 51-62.
40. Fulco M,Cen Y,Zhao P,et al.Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.Dev Cell. 2008;14 (5): 661-73.
41. Dvir-Ginzberg M,Gagarina V,Lee EJ,Hall DJ.Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and NAMPT.J Biol Chem. 2008;283 (52): 36300-10.
42. Potente M,Ghaeni L,Baldessari D,et al.SIRT1 controls endothelial angiogenic functions during vascular growth.Genes Dev. 2007;21 (20): 2644-58.
43. Prozorovski T,Schulze-Topphoff U,Glumm R,et al.Sirt1 contributes critically to the redox-dependent fate of neural progenitors.Nat Cell Biol. 2008;10 (4): 385-94.
44. Backesjo CM,Li Y,Lindgren U,Haldosen LA.Activation of sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.J Bone Miner Res. 2006;21 (7): 993-1002.
45. Matsui K,Ezoe S,Oritani K,et al.NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells.Biochem Biophys Res Commun. 2012;418 (4): 811-7.
46. Blander G,Bhimavarapu A,Mammone T,et al.SIRT1 promotes differentiation of normal human keratinocytes.J Invest Dermatol. 2009;129 (1): 41-9.
47. Rodgers JT,Lerin C,Haas W,Gygi SP,Spiegelman BM,Puigserver P.Nutrient control of glucose homeostasis through a complex of PGC-1[alpha] and SIRT1.Nature. 2005;434 (7029): 113-8.
48. Rodgers JT,Puigserver P.Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1.PNAS. 2007;104 (31): 12861-6.
49. Liu Y,Dentin R,Chen D,et al.A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.Nature. 2008;456 (7219): 269-73.
50. Milne JC,Lambert PD,Schenk S,et al.Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.Nature. 2007;450 (7170): 712-6.
51. Pfluger PT,Herranz D,Velasco-Miguel S,Serrano M,Tschop MH.Sirt1 protects against high-fat diet-induced metabolic damage.Proc Natl Acad Sci U S A. 2008;105 (28): 9793-8.
52. Yang SR,Wright J,Bauter M,Seweryniak K,Kode A,Rahman I.Sirtuin regulates cigarette smoke induced pro-inflammatory mediators release via RelA/p65 NF-{kappa}B in macrophages in vitro and in rat lungs in vivo.Am J Physiol Lung Cell Mol Physiol. 2007;292:L567-76.
53. Stein MA,Lohmann C,Schafer N,et al.SIRT1 protects against atherosclerosis by decreasing macrophage infiltration and foam cell formation.Eur Heart J. 2010;31 (18): 2301-9.
54. McBurney MW,Yang X,Jardine K,et al.The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis.Mol Cell Biol. 2003;23 (1): 38-54.
55. Cheng HL,Mostoslavsky R,Saito S,et al.Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.PNAS. 2003;100 (19): 10794-9.
56. Seifert EL,Caron AZ,Morin K,et al.SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice.FASEB J. 2012;26 (2): 555-66.
57. Kamel C,Abrol M,Jardine K,He X,McBurney MW.SirT1 fails to affect p53-mediated biological functions.Aging Cell. 2006;5 (1): 81-8.
58. Kolthur-Seetharam U,Dantzer F,McBurney MW,de Murcia G,Sassone-Corsi P.Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage.Cell Cycle. 2006;5 (8): 873-7.
59. Rajamohan SB,Pillai VB,Gupta M,et al.SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly (ADP-ribose) polymerase 1.Mol Cell Biol. 2009;29 (15): 4116-29.
60. El Ramy R,Magroun N,Messadecq N,et al.Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes.Cell Mol Life Sci. 2009;66 (19): 3219-34.
61. Boily G,He XH,Jardine K,McBurney MW.Disruption of Igfbp1 fails to rescue the phenotype of Sirt1-/- mice.Exp Cell Res. 2010;316 (13): 2189-93.
62. Boily G,Seifert EL,Bevilacqua L,et al.SirT1 regulates energy metabolism and response to caloric restriction in mice.PLoS ONE. 2008;3 (3): e1759.
63. Kolthur-Seetharam U,Teerds K,de Rooij DG,et al.The histone deacetylase SIRT1 controls male fertility in mice through regulation of hypothalamic-pituitary gonadotropin signaling.Biol Reprod. 2009;80 (2): 384-91.
64. Sequeira J,Boily G,Bazinet S,et al.sirt1-null mice develop an autoimmune-like condition.Exp Cell Res. 2008;314 (16): 3069-74.
65. Zhang J,Lee SM,Shannon S,et al.The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice.J Clin Invest. 2009;119 (10): 3048-58.
66. Gabay O,Sanchez C,Dvir-Ginzberg M,et al.Sirt1 enzymatic activity is required for cartilage homeostasis in vivo.Arthritis Rheum. 2013;65 (1): 159-66.
67. Michan S,Li Y,Chou MM,et al.SIRT1 is essential for normal cognitive function and synaptic plasticity.J Neurosci. 2010;30 (29): 9695-707.
68. Panossian L,Fenik P,Zhu Y,Zhan G,McBurney MW,Veasey S.SIRT1 regulation of wakefulness and senescence-like phenotype in wake neurons.J Neurosci. 2011;31 (11): 4025-36.
69. Howitz KT,Bitterman KJ,Cohen HY,et al.Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.Nature. 2003;425 (6954): 191-6.
70. Feige JN,Lagouge M,Canto C,et al.Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.Cell Metab. 2008;8 (5): 347-58.
71. Yamazaki Y,Usui I,Kanatani Y,et al.Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.Am J Physiol Endocrinol Metab. 2009;297 (5): E1179-86.
72. Minor RK,Baur JA,Gomes AP,et al.SRT1720 improves survival and healthspan of obese mice.Sci Rep. 2011;1:70.
73. Kaeberlein M,McDonagh T,Heltweg B,et al.Substrate specific activation fo sirtuins by resveratrol.J Biol Chem. 2005;280 (17): 17038-45.
74. Borra MT,Smith BC,Denu JM.Mechanism of human SIRT1 activation by resveratrol.J Biol Chem. 2005;280 (17): 17187-95.
75. Pacholec M,Chrunyk BA,Cunningham D,et al.SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.J Biol Chem. 2010;285 (11): 8340-51.
76. Huber JL,McBurney MW,DiStefano PS,McDonagh T.SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183.Future Med Chem. 2010;2 (12): 1751-9.
77. Dai H,Kustigian L,Carney D,et al.SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator.J Biol Chem. 2010;285 (43): 32695-703.
78. Nakata R,Takahashi S,Inoue H.Recent advances in the study on resveratrol.Biol Pharm Bull. 2012;35 (3): 273-9.
79. Boily G,He XH,Pearce B,Jardine K,McBurney MW.SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol.Oncogene. 2009;28:2882-93.
80. McBurney MW,Yang X,Jardine K,Bieman M,Th'ng J,Lemieux M.The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells.Mol Cancer Res. 2003;1 (5): 402-9.
81. Langley E,Pearson M,Faretta M,et al.Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.EMBO J. 2002;21 (10): 2383-96.
82. Solomon JM,Pasupuleti R,Xu L,et al.Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.Mol Cell Biol. 2006;26 (1): 28-38.
83. Yuan J,Minter-Dykhouse K,Lou Z.A c-Myc-SIRT1 feedback loop regulates cell growth and transformation.J Cell Biol. 2009;185 (2): 203-11.
84. Xie Y,Zhang J,Xu Y,Shao C.SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells.J Radiat Res (Tokyo). 2012;53 (1): 44-50.
85. Menssen A,Hydbring P,Kapelle K,et al.The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.Proc Natl Acad Sci U S A. 2011;109 (4): E187-96.
86. Herranz D,Maraver A,Canamero M,et al.SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.Oncogene. 2012;:.
87. Powell MJ,Casimiro MC,Cordon-Cardo C,et al.Disruption of a Sirt1 dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation.Cancer Res. 2011;71 (3): 964-75.
88. Hariharan N,Maejima Y,Nakae J,Paik J,DePinho RA,Sadoshima J.Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes.Circ Res. 2010;107 (12): 1470-82.
89. Jeong JK,Moon MH,Lee YJ,Seol JW,Park SY.Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity.Neurobiol Aging. 2013;34 (1): 146-56.
90. Jang SY,Kang HT,Hwang ES.Nicotinamide-induced mitophagy: an event mediated by high NAD+/NADH ratio and SIRT1 activation.J Biol Chem. 2012;287 (23): 19304-14.
91. Hwang JW,Chung S,Sundar IK,et al.Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD.Arch Biochem Biophys. 2010;500 (2): 203-9.
92. Zhang Z,Lowry SF,Guarente L,Haimovich B.Roles of Sirt1 in the acute and restorative phases following induction of inflammation.J Biol Chem. 2010;285 (53): 41391-401.
93. Wang J,Kim TH,Ahn MY,et al.Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells.Int J Oncol. 2012;41 (3): 1101-9.
94. Pardo PS,Boriek AM.An autoregulatory loop reverts the mechanosensitive Sirt1 induction by EGR1 in skeletal muscle cells.Aging (Albany NY). 2012;4 (7): 456-61.
95. Gao Z,Ye J.Inhibition of transcriptional activity of c-JUN by SIRT1.Biochem Biophys Res Commun. 2008;376 (4): 793-6.
96. Kim JE,Chen J,Lou Z.DBC1 is a negative regulator of SIRT1.Nature. 2008;451 (7178): 583-6.
97. Zhao W,Kruse JP,Tang Y,Jung SY,Qin J,Gu W.Negative regulation of the deacetylase SIRT1 by DBC1.Nature. 2008;451 (7178): 587-90.
98. Kim EJ,Kho JH,Kang MR,Um SJ.Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.Mol Cell. 2007;28 (2): 277-90.
99. Sharma A,Gautam V,Costantini S,Paladino A,Colonna G.Interactomic and pharmacological insights on human sirt-1.Front Pharmacol. 2012;3:40.
100. Barabasi AL,Bonabeau E.Scale-free networks.Sci Am. 2003;288 (5): 60-9.
101. Avalos JL,Celic I,Muhammad S,Cosgrove MS,Boeke JD,Wolberger C.Structure of a Sir2 enzyme bound to an acetylated p53 peptide.Mol Cell. 2002;10 (3): 523-35.
102. Autiero I,Costantini S,Colonna G.Human sirt-1: molecular modeling and structure-function relationships of an unordered protein.PLoS ONE. 2009;4 (10): e7350.
103. Iakoucheva LM,Brown CJ,Lawson JD,Obradovic Z,Dunker AK.Intrinsic disorder in cell-signaling and cancer-associated proteins.J Mol Biol. 2002;323 (3): 573-84.
104. Dunker AK,Cortese MS,Romero P,Iakoucheva LM,Uversky VN.Flexible nets: the roles of intrinsic disorder in protein interaction networks.FEBS J. 2005;272 (20): 5129-48.
105. Uversky VN,Oldfield CJ,Dunker AK.Intrinsically disordered proteins in human diseases: introducing the D2 concept.Annu Rev Biophys. 2008;37:215-46.
106. Kaelin WG.Molecular biology: use and abuse of RNAi to study mammalian gene function.Science. 2012;337 (6093): 421-2.
107. Yamagata Y,Parietti V,Stockholm D,et al.Lentiviral transduction of CD34(+) cells induces genome-wide epigenetic modifications.PLoS ONE. 2012;7 (11): e48943.
108. Lee J,Sayed N,Hunter A,et al.Activation of innate immunity is required for efficient nuclear reprogramming.Cell. 2012;151 (3): 547-58.
109. McBurney MW,Yang X,Jardine K,et al.The mammalian SIR2α protein has a role in embryogenesis and gametogenesis.Mol Cell Biol. 2003;23 (1): 38-54.
110. Yuan J,Minter-Dykhouse K,Lou Z.A c-Myc-SIRT1 feedback loop regulates cell growth and transformation.J Cell Biol. 2009;185 (2): 203-11.
111. Yamakuchi M,Lowenstein CJ.MiR-34, SIRT1 and p53: the feedback loop.Cell Cycle. 2009;8 (5): 712-5.
112. Han L,Zhou R,Niu J,McNutt MA,Wang P,Tong T.SIRT1 is regulated by a PPAR{gamma}-SIRT1 negative feedback loop associated with senescence.Nucleic Acids Res. 2010;38 (21): 7458-71.
113. Marshall GM,Liu PY,Gherardi S,et al.SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.PLoS Genet. 2011;7 (6): e1002135.
114. Yamakuchi M.MicroRNA regulation of SIRT1.Front Physiol. 2012;3:68.
115. Yao H,Chung S,Hwang JW,et al.SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.J Clin Invest. 2012;122 (6): 2032-45.
116. Nadtochiy SM,Yao H,McBurney MW,et al.SIRT1 mediated acute cardioprotection.Am J Physiol Heart Circ Physiol. 2011;301 (4): H1506-12.
117. Li Y,Xu W,McBurney MW,Longo VD.SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons.Cell Metab. 2008;8 (1): 38-48.
118. Chen D,Bruno J,Easlon E,et al.Tissue-specific regulation of SIRT1 by calorie restriction.Genes Dev. 2008;22 (13): 1753-7.
119. Banks AS,Kon N,Knight C,et al.SirT1 gain of function increases energy efficiency and prevents diabetes in mice.Cell Metab. 2008;8 (4): 333-41.
120. Escande C,Chini CCS,Nin V,et al.Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.J Clin Invest. 2010;120 (2): 545-58.
121. Purushotham A,Schug TT,Xu Q,Surapureddi S,Guo X,Li X.Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.Cell Metab. 2009;9 (4): 327-38.
122. Wang RH,Li C,Deng CX.Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition.Int J Biol Sci. 2010;6 (7): 682-90.
123. Sena LA,Chandel NS.Physiological roles of mitochondrial reactive oxygen species.Mol Cell. 2012;48 (2): 158-67.
124. Brunet A,Sweeney LB,Sturgill JF,et al.Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.Science. 2004;303 (5666): 2011-5.
125. Ford J,Ahmed S,Allison S,Jiang M,Milner J.JNK2-dependent regulation of SIRT1 protein stability.Cell Cycle. 2008;7 (19): 3091-7.
126. Cohen HY,Miller C,Bitterman KJ,et al.Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.Science. 2004;305 (5682): 390-2.
127. Oberdoerffer P,Michan S,McVay M,et al.SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging.Cell. 2008;135 (5): 907-18.
128. Sasaki T,Maier B,Bartke A,Scrable H.Progressive loss of SIRT1 with cell cycle withdrawal.Aging Cell. 2006;5 (5): 413-22.
129. Ota H,Tokunaga E,Chang K,et al.Sirt1 inhibitor, sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.Oncogene. 2006;25 (2): 176-85.
130. Abdelmohsen K,Pullmann J,Lal A,et al.Phosphorylation of HuR by Chk2 regulates SIRT1 expression.Mol Cell. 2007;25 (4): 543-57.
131. van der Veer E,Ho C,O'Neil C,et al.Extension of human cell lifespan by nicotinamide phosphoribosyltransferase.J Biol Chem. 2007;282 (15): 10841-5.
132. Huang J,Gan Q,Han L,et al.SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts.PLoS ONE. 2008;3 (3): e1710.
133. Chua KF,Mostoslavsky R,Lombard DB,et al.Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress.Cell Metab. 2005;2 (1): 67-76.
134. Ford J,Jiang M,Milner J.Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.Cancer Res. 2005;65 (22): 10457-63.
135. Fu M,Liu M,Sauve AA,et al.The hormonal control of androgen receptor function through SIRT1.Mol Cell Biol. 2006;26 (21): 8122-35.
136. Kabra N,Li Z,Chen L,et al.SirT1 is an inhibitor of proliferation and tumor formation in colon cancer.J Biol Chem. 2009;284 (27): 18210-7.
137. Stunkel W,Peh BK,Tan YC,et al.Function of the SIRT1 protein deacetylase in cancer.Biotechnol J. 2007;2 (11): 1360-8.
138. Wu M,Wei W,Xiao X,et al.Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.Med Oncol. 2012;29 (5): 3240-9.
139. Jang KY,Kim KS,Hwang SH,et al.Expression and prognostic significance of SIRT1 in ovarian epithelial tumours.Pathology. 2009;41 (4): 366-71.
140. Jang SH,Min KW,Paik SS,Jang KS.Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.J Clin Pathol. 2012;65 (8): 735-9.
141. Wang RH,Zheng Y,Kim HS,et al.Interplay among BRCA1, SIRT1, and survivin during BRCA1-associated tumorigenesis.Mol Cell. 2008;32 (1): 11-20.
142. Land H,Parada LF,Weinberg RA.Tumourigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.Nature. 1986;304:596-601.
143. Herranz D,Munoz-Martin M,Canamero M,et al.Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.Nat Commun. 2010;1 (1): 1-8.
144. Firestein R,Blander G,Michan S,et al.The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.PLoS ONE. 2008;3 (4): e2020.
145. Weinstein IB,Joe A.Oncogene addiction.Cancer Res. 2008;68 (9): 3077-80.
146. Andersen JL,Thompson JW,Lindblom KR,et al.A biotin switch-based proteomics approach identifies 14-3-3zeta as a target of sirt1 in the metabolic regulation of caspase-2.Mol Cell. 2011;43 (5): 834-42.
147. Lim JH,Lee YM,Chun YS,Chen J,Kim JE,Park JW.Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.Mol Cell. 2010;38 (6): 864-78.
148. Zocchi L,Sassone-Corsi P.SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression.Epigenetics. 2012;7 (7): 695-700.
149. Sundaresan NR,Pillai VB,Wolfgeher D,et al.The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.Sci Signal. 2011;4 (182): ra46.
150. Sestito R,Madonna S,Scarponi C,et al.STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.FASEB J. 2010;25 (3): 916-27.
151. Hallows WC,Lee S,Denu JM.Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases.PNAS. 2006;103 (27): 10230-5.
152. Dioum EM,Chen R,Alexander MS,et al.Regulation of hypoxia-inducible factor 2{alpha} signaling by the stress-responsive deacetylase sirtuin 1.Science. 2009;324 (5932): 1289-93.
153. Zhao X,Sternsdorf T,Bolger TA,Evans RM,Yao TP.Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.Mol Cell Biol. 2005;25 (19): 8456-64.
154. Vaquero A,Scher M,Erdjument-Bromage H,Tempst P,Serrano L,Reinberg D.SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.Nature. 2007;450 (7168): 440-4.
155. Das C,Lucia MS,Hansen KC,Tyler JK.CBP/p300-mediated acetylation of histone H3 on lysine 56.Nature. 2009;459 (7243): 113-7.
156. Lovaas JD,Zhu L,Chiao CY,Byles V,Faller DV,Dai Y.SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.Prostate. 2012;:.
157. Hallows WC,Yu W,Denu JM.Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1-mediated deacetylation.J Biol Chem. 2011;287 (6): 3850-8.
158. Shimazu T,Komatsu Y,Nakayama KI,Fukazawa H,Horinouchi S,Yoshida M.Regulation of SV40 large T-antigen stability by reversible acetylation.Oncogene. 2006;25 (56): 7391-400.
159. Yamamori T,DeRicco J,Naqvi A,et al.SIRT1 deacetylates APE1 and regulates cellular base excision repair.Nucleic Acids Res. 2010;38 (3): 832-45.
160. Qiang L,Lin HV,Kim-Muller JY,Welch CL,Gu W,Accili D.Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through creb deacetylation.Cell Metab. 2011;14 (6): 758-67.
161. Nemoto S,Fergusson MM,Finkel T.SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1alpha.J Biol Chem. 2005;280 (16): 16456-60.
162. Pagans S,Pedal A,North BJ,et al.SIRT1 regulates HIV transcription via Tat deacetylation.PLoS Biol. 2005;3 (2): e41.
163. Peng L,Yuan Z,Ling H,et al.SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities.Mol Cell Biol. 2011;31 (23): 4720-34.
164. Yuan Z,Zhang X,Sengupta N,Lane WS,Seto E.SIRT1 regulates the function of the Nijmegen breakage syndrome protein.Mol Cell. 2007;27 (1): 149-62.
165. Kelly TJ,Lerin C,Haas W,Gygi SP,Puigserver P.GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation.J Biol Chem. 2009;284 (30): 19945-52.
166. Min SW,Cho SH,Zhou Y,et al.Acetylation of tau inhibits its degradation and contributes to tauopathy.Neuron. 2010;67 (6): 953-66.
167. Mattagajasingh I,Kim CS,Naqvi A,et al.SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase.PNAS. 2007;104 (37): 14855-60.
168. Hirschey MD,Shimazu T,Capra JA,Pollard KS,Verdin E.SIRT1 and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2.Aging (Albany NY). 2011;3 (6): 635-42.
169. Yeung F,Hoberg JE,Ramsey CS,et al.Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.EMBO J. 2004;23 (12): 2369-80.
170. Akieda-Asai S,Zaima N,Ikegami K,et al.SIRT1 regulates thyroid-stimulating hormone release by enhancing PIP5Kgamma activity through deacetylation of specific lysine residues in mammals.PLoS ONE. 2010;5 (7): e11755.
171. Zhou Y,Schmitz KM,Mayer C,Yuan X,Akhtar A,Grummt I.Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing.Nat Cell Biol. 2009;11 (8): 1010-6.
172. Wilson BJ,Tremblay AM,Deblois G,Sylvain-Drolet G,Giguere V.An acetylation switch modulates the transcriptional activity of estrogen-related receptor {alpha}.Mol Endocrinol. 2010;24 (7): 1349-58.
173. Libert S,Pointer K,Bell EL,et al.SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive.Cell. 2011;147 (7): 1459-72.
174. Qiang L,Wang L,Kon N,et al.Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma.Cell. 2012;150 (3): 620-32.
175. Yamagata K,Kitabayashi I.Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX.Biochem Biophys Res Commun. 2009;390 (4): 1355-60.
176. Yang Y,Hou H,Haller EM,Nicosia SV,Bai W.Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.EMBO J. 2005;24 (5): 1021-32.
177. Yang J,Kong X,Martins-Santos ME,et al.The activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating HNF4alpha.J Biol Chem. 2009;284 (40): 27042-53.
178. Guarani V,Deflorian G,Franco CA,et al.Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase.Nature. 2011;473 (7346): 234-8.
179. Ikenoue T,Inoki K,Zhao B,Guan KL.PTEN acetylation modulates its interaction with PDZ domain.Cancer Res. 2008;68 (17): 6908-12.
180. Jeong H,Cohen DE,Cui L,et al.Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.Nat Med. 2011;18 (1): 159-65.
181. Motta MC,Divecha N,Lemieux M,et al.Mammalian SIRT1 represses forkhead transcription factors.Cell. 2004;116:551-63.
182. Westerheide SD,Anckar J,Stevens SM,Sistonen L,Morimoto RI.Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1.Science. 2009;323 (5917): 1063-6.
183. Kawai Y,Garduno L,Theodore M,Yang J,Arinze IJ.Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleo-cytoplasmic localization.J Biol Chem. 2010;286 (9): 7629-40.
184. Donmez G,Wang D,Cohen DE,Guarente L.SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.Cell. 2010;142 (2): 320-32.
185. Li K,Casta A,Wang R,et al.Regulation of WRN protein cellular localization and enzymatic activities by SIRT1 mediated deacetylation.J Biol Chem. 2008;283 (12): 7590-8.
186. Bereshchenko OR,Gu W,Dalla-Favera R.Acetylation inactivates the transcriptional repressor BCL6.Nat Genet. 2002;32 (4): 606-13.
187. van der Horst A,Tertoolen LGJ,Vries-Smits LMM,Frye RA,Medema RH,Burgering BMT.FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1.J Biol Chem. 2004;279 (28): 28873-9.
188. Zhang J.The direct involvement of SirT1 in insulin-induced IRS-2 tyrosine phosphorylation.J Biol Chem. 2007;282 (47): 34356-64.
189. Wong S,Weber JD.Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.Biochem J. 2007;407 (3): 451-60.
190. Wang FM,Ouyang HJ.Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation.Biochem J. 2011;433 (1): 245-52.
191. van Loosdregt J,Vercoulen Y,Guichelaar T,et al.Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.Blood. 2010;115 (5): 965-74.
192. Jeong J,Juhn K,Lee H,et al.SIRT1 promotes DNA repair activity and deacetylation of Ku70.Exp Mol Med. 2007;39 (1): 8-13.
193. Xue Z,Lv X,Song W,et al.SIRT1 deacetylates SATB1 to facilitate MARHS2-MAR{epsilon} interaction and promote {epsilon}-globin expression.Nucleic Acids Res. 2012;40 (11): 4804-15.
194. Fan W,Luo J.SIRT1 regulates UV-induced DNA repair through deacetylating XPA.Mol Cell. 2010;39 (2): 247-58.
195. Kemper JK,Xiao Z,Ponugoti B,et al.FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.Cell Metab. 2009;10 (5): 392-404.
196. Lan F,Cacicedo JM,Ruderman N,Ido Y.SIRT1 modulation of the acetylation status, cytosolic localization and activity of LKB1: possible role in AMP-activated protein kinase activation.J Biol Chem. 2008;283 (41): 27628-35.
197. Dai JM,Wang ZY,Sun DC,Lin RX,Wang SQ.SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity.J Cell Physiol. 2007;210 (1): 161-6.
198. Kume S,Haneda M,Kanasaki K,et al.SIRT1 inhibits TGFbeta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation.J Biol Chem. 2007;282 (1): 151-8.
199. Hata S,Hirayama J,Kajiho H,et al.A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents.J Biol Chem. 2012;287 (26): 22089-98.
200. Wu X,Kong X,Chen D,et al.SIRT1 links CIITA deacetylation to MHC II activation.Nucleic Acids Res. 2011;39 (22): 9549-58.
201. Stankovic-Valentin N,Deltour S,Seeler J,et al.An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved {psi}KxEP motif in the tumor suppressor HIC1 (hypermethylated in cancer 1) regulates transcriptional repression activity.Mol Cell Biol. 2007;27 (7): 2661-75.
202. Li X,Zhang S,Blander G,Tse JG,Krieger M,Guarente L.SIRT1 deacetylates and positively regulates the nuclear receptor LXR.Mol Cell. 2007;28 (1): 91-106.
203. Ichi S,Boshnjaku V,Shen YW,et al.Role of Pax3 acetylation in the regulation of Hes1 and Neurog2.Mol Biol Cell. 2011;22 (4): 503-12.
204. Ponugoti B,Kim DH,Xiao Z,et al.SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.J Biol Chem. 2010;285 (44): 33959-70.
205. Fujita Y,Yamaguchi A,Hata K,Endo M,Yamaguchi N,Yamashita T.Zyxin is a novel interacting partner for SIRT1.BMC Cell Biol. 2009;10 (1): 6.
206. Xia J,Wu X,Yang Y,et al.SIRT1 deacetylates RFX5 and antagonizes repression of collagen type I (COL1A2) transcription in smooth muscle cells.Biochem Biophys Res Commun. 2012;428 (2): 264-70.
207. Senawong T,Peterson VJ,Avram D,et al.Involvement of the histone deacetylase SIRT1 in COUP-TF-interacting protein 2-mediated transcriptional repression.J Biol Chem. 2003;278 (44): 43041-50.
208. Wang C,Chen L,Hou X,et al.Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.Nat Cell Biol. 2006;8 (9): 1025-31.
209. Ghosh HS,Reizis B,Robbins PD.SIRT1 associates with eIF2-alpha and regulates the cellular stress response.Sci Rep. 2011;1:150.
210. Lin Z,Yang H,Kong Q,et al.USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development.Mol Cell. 2012;46 (4): 484-94.
211. Takata T,Ishikawa F.Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression.Biochem Biophys Res Commun. 2003;301 (1): 250-7.
212. Niwa H,Burdon T,Chambers I,Smith A.Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3.Genes Dev. 1998;12:2048-60.
213. Ghosh HS,Spencer JV,Ng B,McBurney MW,Robbins PD.Sirt1 interacts with transducin-like enhancer of split-1 to inhibit NF-kappaB mediated transcription.Biochem J. 2007;408 (1): 105-11.
214. Ghosh HS,McBurney M,Robbins PD.SIRT1 negatively regulates the mammalian target of rapamycin.PLoS ONE. 2010;5 (2): e9199.
215. Shannon P,Markiel A,Ozier O,et al.Cytoscape: a software environment for integrated models of biomolecular interaction networks.Genome Res. 2003;13 (11): 2498-504.